tradingkey.logo

Resmed Inc

RMD
View Detailed Chart

236.560USD

-1.180-0.50%
Close 04/30, 16:00ETQuotes delayed by 15 min
34.68BMarket Cap
27.78P/E TTM

Resmed Inc

236.560

-1.180-0.50%
Intraday
1m
30m
1h
D
W
M
D

Today

-0.50%

5 Days

+10.32%

1 Month

+7.42%

6 Months

-2.44%

Year to Date

+3.44%

1 Year

+10.55%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 19 analysts
BUY
Current Rating
260.563
Target Price
9.60%
Rising Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

91
Total
4
Median
7
Average
Company name
Ratings
Analysts
Resmed Inc
RMD
19
Boston Scientific Corp
BSX
34
Edwards Lifesciences Corp
EW
33
Intuitive Surgical Inc
ISRG
33
Thermo Fisher Scientific Inc
TMO
33
Veeva Systems Inc
VEEV
32
1
2
3
...
18

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

1m
15m
30m
1h
D
W
M
1m
15m
30m
D
Buy
Sell(1)
Neutral(2)
Buy(7)
Indicators
Sell(1)
Neutral(2)
Buy(1)
Indicators
Value
Direction
MACD(12,26,9)
7.387
Neutral
RSI(14)
62.340
Neutral
STOCH(KDJ)(9,3,3)
89.800
Overbought
ATR(14)
8.865
Low Volatility
CCI(14)
127.309
Buy
Williams %R
5.085
Overbought
TRIX(12,20)
-0.054
Sell
StochRSI(14)
100.000
Overbought
Moving Average
Sell(0)
Neutral(0)
Buy(6)
Indicators
Value
Direction
MA5
231.660
Buy
MA10
222.162
Buy
MA20
217.925
Buy
MA50
228.226
Buy
MA100
233.944
Buy
MA200
230.639
Buy

News

More news coming soon, stay tuned...

Company

ResMed Inc. is a holding company. The Company, through its subsidiaries, in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep disordered breathing (SDB), chronic obstructive pulmonary disease, neuromuscular disease and other chronic diseases. Its segments include Sleep and Breathing Health segment and the Residential Care Software segment. It also operates a Software as a Service (SaaS) business in the United States and Germany that includes out-of-hospital software platforms designed to support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. Its products and solutions are designed to improve patients' quality of life and reduce the impact of chronic disease. Its cloud-based digital health software applications, along with its devices, are designed to provide connected care.
Company codeRMD
CompanyResmed Inc
CEOMr. Michael J. (Mick) Farrell
Websitehttps://www.resmed.com/